-
STRO Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Sutro Biopharma (STRO)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 175.44 mm | 175.44 mm | 175.44 mm | 175.44 mm | 175.44 mm | 175.44 mm |
Cash burn (monthly) | (no burn) | (no burn) | 22.64 mm | 10.66 mm | 21.51 mm | 8.81 mm |
Cash used (since last report) | n/a | n/a | 119.93 mm | 56.48 mm | 113.92 mm | 46.67 mm |
Cash remaining | n/a | n/a | 55.51 mm | 118.96 mm | 61.52 mm | 128.76 mm |
Runway (months of cash) | n/a | n/a | 2.5 | 11.2 | 2.9 | 14.6 |
13F holders | Current |
---|---|
Total holders | 126 |
Opened positions | 23 |
Closed positions | 32 |
Increased positions | 40 |
Reduced positions | 36 |
13F shares | Current |
---|---|
Total value | 113.16 bn |
Total shares | 72.49 mm |
Total puts | 33.60 k |
Total calls | 127.60 k |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 7.59 mm | $13.97 bn |
Suvretta Capital Management | 7.46 mm | $13.73 bn |
Vanguard | 4.21 mm | $7.74 bn |
Kynam Capital Management | 3.64 mm | $6.70 bn |
MRK Merck & Co. | 2.72 mm | $5.01 bn |
Vestal Point Capital | 2.57 mm | $4.73 bn |
Citadel Advisors | 2.46 mm | $4.52 bn |
Adage Capital Management | 2.25 mm | $8.01 mm |
Point72 Asset Management | 2.20 mm | $4.04 bn |
Samsara BioCapital | 2.20 mm | $4.04 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Mar 25 | Edward C Albini | Common Stock | Payment of exercise | Dispose F | No | No | 1.36 | 3,594 | 4.89 k | 132,081 |
5 Mar 25 | Edward C Albini | Common Stock | Option exercise | Acquire M | No | No | 0 | 8,750 | 0.00 | 135,675 |
5 Mar 25 | Edward C Albini | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 8,750 | 0.00 | 0 |
5 Mar 25 | Fitzpatrick Linda A | Common Stock | Payment of exercise | Dispose F | No | No | 1.36 | 3,594 | 4.89 k | 95,433 |
5 Mar 25 | Fitzpatrick Linda A | Common Stock | Option exercise | Acquire M | No | No | 0 | 8,750 | 0.00 | 99,027 |
5 Mar 25 | Fitzpatrick Linda A | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 8,750 | 0.00 | 0 |
5 Mar 25 | Newell William J | Common Stock | Payment of exercise | Dispose F | No | No | 1.36 | 6,708 | 9.12 k | 292,531 |
5 Mar 25 | Newell William J | Common Stock | Option exercise | Acquire M | No | No | 0 | 18,750 | 0.00 | 299,239 |
5 Mar 25 | Newell William J | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 18,750 | 0.00 | 0 |
4 Mar 25 | Jane Chung | Common Stock | Payment of exercise | Dispose F | No | No | 1.42 | 2,334 | 3.31 k | 98,308 |